Science
News
New treatment on trial at NCIS offers hope for advanced cancer patients
The National University Cancer Institute, Singapore (NCIS) is set to trial a new and potentially more effective type of chimeric antigen receptor (CAR) T-cell therapy that could increase cancer patients’ access to treatment.